Longboard Pharmaceuticals Statistics
Total Valuation
NWXPF has a market cap or net worth of 7.68 million. The enterprise value is 5.89 million.
| Market Cap | 7.68M |
| Enterprise Value | 5.89M |
Important Dates
The next estimated earnings date is Thursday, October 9, 2025.
| Earnings Date | Oct 9, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 105.58M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +1.29% |
| Shares Change (QoQ) | +1.69% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 77.39M |
Valuation Ratios
The trailing PE ratio is 15.82.
| PE Ratio | 15.82 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 3.28 |
| P/TBV Ratio | 3.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 9.39 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 12.13 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 117.36, with a Debt / Equity ratio of 0.00.
| Current Ratio | 117.36 |
| Quick Ratio | 116.91 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -864.34 |
Financial Efficiency
Return on equity (ROE) is 22.23% and return on invested capital (ROIC) is -35.88%.
| Return on Equity (ROE) | 22.23% |
| Return on Assets (ROA) | -35.60% |
| Return on Invested Capital (ROIC) | -35.88% |
| Return on Capital Employed (ROCE) | -54.37% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NWXPF has paid 370,723 in taxes.
| Income Tax | 370,723 |
| Effective Tax Rate | 43.30% |
Stock Price Statistics
The stock price has increased by +41.29% in the last 52 weeks. The beta is 0.73, so NWXPF's price volatility has been lower than the market average.
| Beta (5Y) | 0.73 |
| 52-Week Price Change | +41.29% |
| 50-Day Moving Average | 0.10 |
| 200-Day Moving Average | 0.11 |
| Relative Strength Index (RSI) | 37.26 |
| Average Volume (20 Days) | 1,185 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | -26,125 |
| Operating Income | -1.27M |
| Pretax Income | 856,236 |
| Net Income | 485,513 |
| EBITDA | -1.27M |
| EBIT | -1.27M |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 1.79 million in cash and 8,186 in debt, giving a net cash position of 1.79 million.
| Cash & Cash Equivalents | 1.79M |
| Total Debt | 8,186 |
| Net Cash | 1.79M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 2.34M |
| Book Value Per Share | 0.02 |
| Working Capital | 2.33M |
Cash Flow
| Operating Cash Flow | 818,025 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NWXPF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 78.69% |
| Buyback Yield | -1.29% |
| Shareholder Yield | n/a |
| Earnings Yield | 6.32% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |